SCHEMBL29609231

SCHEMBL29609231

CC(C)(C)OC(=O)N1CC2(Cc3ccccc3C2=O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.44
USP30 Q70CQ3 1/20 0.43
NR1H2 P55055 1/20 0.43
PDK4 Q16654 1/20 0.41
NAMPT P43490 3/20 0.41
RORC P51449 3/20 0.40
GPR119 Q8TDV5 1/20 0.40
PDK2 Q15119 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
BUB1 O43683 1/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
HTR2B P41595 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
SMARCA2 P51531 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21855879 1.00 MAPK1 (0.44) MAPK1USP30NR1H2PDK4NAMPT
SCHEMBL1912719 0.87 USP30 (0.47) MAPK1USP30PDK4NAMPTGPR119
SCHEMBL25401400 0.83 NR1H2 (0.40) USP30NR1H2RORCGPR119PDK2
SCHEMBL1466048 0.83 ESR2 (0.42) USP30NR1H2RORCBUB1DDB1
SCHEMBL25309341 0.83 OXTR (0.43) USP30NR1H2RORCBUB1
SCHEMBL31089984 0.83 OXTR (0.43) USP30NR1H2RORCBUB1
SCHEMBL26284418 0.80 USP30 (0.41) MAPK1USP30NR1H2PDK4NAMPT
SCHEMBL25403648 0.80 USP30 (0.41) USP30PDK4RORCGPR119PDK2
SCHEMBL25298992 0.80 MAPK1 (0.51) MAPK1USP30NR1H2NAMPTRORC
SCHEMBL22493807 0.79 CHRM2 (0.43) MAPK1NAMPTGPR119CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2025-02-27 US disclosed
US-12187721-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2025-01-07 US disclosed
CN-114341124-B Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2024-09-20 CN disclosed
CN-114539340-B CD73 inhibitor and pharmaceutical application thereof 润佳(苏州)医药科技有限公司 2024-06-07 CN disclosed
EP-4251633-A1 CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2023-10-04 EP disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 EP disclosed
WO-2022109741-A1 CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2022-06-02 WO disclosed
CN-114539340-A CD73 inhibitor and pharmaceutical application thereof 润佳(苏州)医药科技有限公司 2022-05-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C MAPK1 164/4885USP30 1702/4885NR1H2 3411/4885
US-12187721-B2 Protein tyrosine phosphatase inhibitors PPM1A, PTP4A1, PPP5C MAPK1 184/4885USP30 1678/4885NR1H2 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.